Growth Metrics

ImmunityBio (IBRX) Cash from Investing Activities (QoQ) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 ImmunityBio 7.72 Bn 7.34 Bn 43.97 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -172.64%
Dec 31, 2025 124.03%
Sep 30, 2025 -1,023.53%
Jun 30, 2025 -490.94%
Mar 31, 2025 -58.01%
Dec 31, 2024 -84.88%
Sep 30, 2024 226.30%
Jun 30, 2024 -44.55%
Mar 31, 2024 -1,683.90%
Dec 31, 2023 114.39%
Sep 30, 2023 -81.67%
Jun 30, 2023 -1.41%
Mar 31, 2023 55.10%
Dec 31, 2022 -1,517.64%
Sep 30, 2022 -101.00%
Jun 30, 2022 268.33%
Mar 31, 2022 49.70%
Dec 31, 2021 -1,402.23%
Sep 30, 2021 0.89%
Jun 30, 2021 -67.06%
Mar 31, 2021 322.07%
Dec 31, 2020 113.32%
Sep 30, 2020 -470.73%
Jun 30, 2020 9.15%
Mar 31, 2020 51.14%
Dec 31, 2019 -46.71%
Sep 30, 2019 52.70%
Jun 30, 2019 158.47%
Mar 31, 2019 -222.28%
Dec 31, 2018 -5.69%
Sep 30, 2018 -21.12%
Jun 30, 2018 632.64%
Mar 31, 2018 -85.20%
Dec 31, 2017 183.49%
Sep 30, 2017 -87.75%
Jun 30, 2017 254.28%
Mar 31, 2017 289.48%
Dec 31, 2016 -223.47%
Sep 30, 2016 167.53%
Jun 30, 2016 90.04%
Mar 31, 2016 40.79%
Dec 31, 2015 -26,339.32%
Sep 30, 2015 -9.05%
Jun 30, 2015 67.83%
Mar 31, 2015 -6,086.67%
Dec 31, 2014 84.04%
Sep 30, 2014 -889.47%
Jun 30, 2014 -1,050.00%